Latest Revenue Streaming News

Sagalio Energy reported stable production of 510 tons of oil and sales revenue of nearly US$124,000 for the December 2024 quarter, navigating slight price volatility while expanding output modestly.

Entyr Limited has launched a $9.5 million capital raising via a Share Purchase Plan and Placement Offer, aiming to recapitalize and return to ASX trading following its recent voluntary administration.

Advanced Braking Technology Ltd (ASX: ABV) reported a robust 24% increase in product sales revenue for Q2 FY25, driven by international expansion and the launch of its innovative BrakeiQ system. The company’s underlying profit also grew by 25%, underscoring operational efficiencies and a strong global pipeline.

Multistack International Limited reported steady sales of water chillers in Q4 2024 while progressing toward a settlement in its arbitration with Danfoss. The company maintains a solid cash position supported by related-party loans as it continues to promote its ORC technology aligned with global carbon reduction goals.

Spacetalk Ltd reports robust growth in paid mobile subscribers and annual recurring revenue for Q2 FY25, underpinned by strategic international expansion and disciplined cost management.

4DMedical has signed a landmark commercial agreement with Qscan Radiology Clinics, marking its first Australian contract to integrate both Pulmonary Function and Pulmonary Structure imaging products.

SomnoMed Limited reported a solid cash flow performance for Q4 2024, with operating activities generating a net inflow of $1.525 million and ending the quarter with $18.5 million in cash reserves.

FAR Limited reports robust production from Senegal’s Sangomar field and a solid cash position, while anticipating a contingent payment from Woodside Energy that could reach US$55 million.

Raptis Group Limited reported stable income from its caretaking and letting operations for the December 2024 quarter, while navigating a personal injury claim and exploring a new residential resort project on the Gold Coast.

Raptis Group Limited reported a positive net cash inflow from operating activities of $54,509 for the quarter ended December 31, 2024, ending with $303,102 in cash and equivalents. The company recorded no investing or financing cash flows during the period.

Memphasys Limited marks a pivotal quarter with the completion of clinical trials for its Felix™ System, strategic market expansions in Greater China and the Middle East, and a successful capital raise to fuel growth.

InhalerX Limited reported a negative cash flow for the December quarter despite securing a substantial $38.5 million funding facility aimed at advancing its clinical trials. The company has yet to draw on this facility, maintaining a cautious cash position as it progresses its drug development programs.